Surgical resection including peri-operative chemotherapy (adjuvant and neoadjuvant)

European Journal of Cancer, Supplement

Volumn 1, Issue 6 SPEC. ISS., 2003, Pages 181-187

  Nordlinger, Bernard ^a   Benoist, Stéphane ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ARTIFICIAL EMBOLISM; BILE DUCT DISEASE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL TRIAL; CONFERENCE PAPER; CONVALESCENCE; HUMAN; LIVER METASTASIS; LIVER RESECTION; LONG TERM CARE; MORBIDITY; PERIOPERATIVE PERIOD; PORTAL VEIN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM CARCINOMA; REOPERATION; RISK FACTOR; SIDE EFFECT; SURGICAL TECHNIQUE; SYSTEMIC DISEASE; TOXICITY; TREATMENT OUTCOME;

EID: 5144221800     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6349(03)90022-X     Document Type: Conference Paper

References (31)

1. Stangl R., Altendorf-Hofmann A., Charnley R.M., Scheele J. Factors influencing the natural history of colorectal liver. Lancet. 343:1994;1405-1410
2. Wilson S.M., Adson M.A. Surgical treatment of hepatic metastases from colorectal cancer. Arch Surg. 111:1976;330-333
3. Wanebo H.J., Semoglou C., Attiyeh F., et al. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg. 135:1978;81-85
4. Pichlmayr R. Is there a place for liver grafting for malignancy? 5th ed. Transpl Proc. 20:1988;478-482
5. Timothy G.J., Greig J.D., Crosbie J.L., Miles W.F.A., Garden O.J. Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg. 6:1994;711-719
6. Nordlinger B., Jaeck D., Guiguet M., Vaillant J.C., Balladur P., Schaal J.C. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. Nordlinger B., Jaeck D. Treatment of hepatic metastases of colorectal cancer. 1992;129-146 Springer-Verlag, Paris
7. Zacherl J., Scheuba C., Imhof N., et al. Current value of intraoperative sonography during surgery for hepatic neoplasms. World J Surg. 26:2002;550-554
8. Bismuth H., Houssin D., Castaing D. Major and minor segmentectomies "réglées" in liver surgery. World J Surg. 6:1982;10-24
9. Starzl T.E., Bell R.H., Beart R.W., Putnam C.W. Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet. 141:1975;429-437
10. Elias D., Detroz B., Lasser P., Plaud B., Jerbi G. Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg. 169:1995;254-260
11. Nordlinger B., Quilichini M.A., Pare R., Hannoun L., Delva E., Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrence in 80 patients. Ann Surg. 205:1987;256-263
12. Doci R., German L., Bigmani P., Montalto F., Moranito A., Bozzetti F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinant. Br J Surg. 78:1991;797-801
13. Scheele J., Stang R., Altendorf-Hofmann A., Paul M. Resection of colorectal liver metastases. World J Surg. 19:1995;59-71
14. Jamison R.L., Donohue J.H., Nagorney D.M., et al. Hepatic resections for metastatic colorectal cancer. Results in cure for some patients. Arch Surg. 132:1997;505-511
15. Fong Y., Former J., Sun R.L., Brennan M.E., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 230:1999;309-318
16. Minagawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann Surg. 231:2000;487-499
17. Gayowski T.J., Iwatsuki S., Madariaga J.R., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 116:1994;703-710
18. Nordlinger B., Guiguet M., Vaillant J-C., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 77:1996;1254-1262
19. Cady B., Jenkins R.L., Steele G.D. Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 227:1998;566-571
20. Lange J.F., Leese T., Castaing D., Bismuth H. Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet. 169:1989;119-126
21. Nordlinger B., Vaillant J.C., Guiguet P., et al. Repeat liver resections for recurrent colorectal metastases: Prolonged survivals. J Clin Oncol. 12:1994;1491-1496
22. Azoulay D., Castaing D., Smail A., et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 231:2000;480-486
23. Elias D., De Baere T., Roche A., Ducreux M., Leclere J., Lasser E. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 86:1999;784-788
24. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy of primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol. 10:1992;904-911
25. Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet. 355:2000;1041-1047
26. Bismuth H., Adam R., Levi F., et al. Resection of non-resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 224:1996;509-520
27. Lorenz M., Muller H.H., Shramm H., et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German cooperative on liver metastases. Ann Surg. 228:1998;756-762
28. Kemeny N., Huang Y., Cohen A., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 341:1999;2039-2048
29. Kemeny M.M., Sudeshna A., Gray B., et al. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol. 20:2002;1499-1505
30. Portier G., Rougier P., Milan C., et al. Adjuvant systemic chemotherapy (CT) using 5-fluorouracil (FU) and folinic acid (FA) after resection of liver metastases (LM) from colorectal (CRC) origin. Results of an intergroup phase III study (trial FFCD - ACHBTH - AURC 9002). 5th ed. J Clin Oncol. 2002; 5th ed. Proc ASCO: #528. 2002
31. Langer B., Bleiberg H., Labianca R., et al. Fluorouracil (FU) plus 1-leucovorin (1-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. 5th ed. J Clin Oncol. 2002; 5th ed. Proc ASCO: #592. 2002